APN News

  • Friday, April, 2024| Today's Market | Current Time: 08:20:10
  • Ricky Sayegh MD talks about the impact of Coronavirus on the U.S. Healthcare Sector

    Published on June 19, 2020

    Increased death counts, infected patients, rising fear and phobia of contracting the virus aren’t the only after-effects of COVID-19. There are other debilitating impacts as well. For instance, there have been face-mask forgeries and hand sanitizer shortages, which hurt the global medical supply chain. Today, the healthcare and pharmaceutical supply chain are suffering from severe issues because of this global pandemic. The majority of clinics, healthcare facilities, and hospitals are facing problems to source, procure, and manage basic medical device stocks to combat novel coronavirus. The global healthcare industry, which also includes the U.S. medical domain, is facing severe challenges.

    Insightful observations on the healthcare domain by Ricky Sayegh MD

    Recently, the Vice President of TractManager asserted that a virus outbreak adds increased pressure on ineffective and costly procurement procedures. Going forward, the results might last even after the crisis ends. In the past few weeks, the U.S. healthcare domain had outpaced other countries in terms of COVID-19 infection. Amongst the increasing pressure, the U.S. medical system had to deal with the harsh truth of material shortage, i.e. the intensive care capacity, ventilators, masks, and healthcare staff. Adequate medicines to treat infected patients was also in short supply.

    According to Ricky Sayegh MD, a medical specialist, supply shortage is limiting the unending efforts of medical fraternity in the U.S. The healthcare providers today are depending on a correct supply chain management policy to ensure there aren’t any supply issues in the future to treat patients in times of a pandemic crisis.

    The vital U.S. medical considerations

    Infiniti Research has listed down two essential considerations for the U.S. medical organizations presently. They are:

    • Managing the medical delivery systems.
    • Managing the supply bottlenecks and deficiency.

    Currently, the U.S. medical systems are running full capacity. Hence, there are demand and supply gaps. The current requirement of this hour is to manage the way patients are getting enrolled and go ahead through multiple nodes of the medical delivery system. Additionally, the medical professionals are also witnessing scarcity in the security medical gears for healthcare workers. The U.S. medical organizations should try to find ways to reduce these bottlenecks so that they can win the fight against this deadly virus outbreak.

    The inefficiencies and wasted expenditures

    The medical facilities stock up the healthcare products that are available during this tight demand. And the unfortunate reality is that most hospitals and clinics are doing this without thinking twice about the budget spending. Such impulsive buying might lead to financial stress later, because of wasted expenditure and procurement inefficiencies. Today, most U.S. hospitals and healthcare units are overstocking the essential protective equipment without careful planning.

    Every medical professional and doctor has a preference for the devices they need urgently to treat the admitted patients at hand. However, a problem will arise as the equipment remains unused and is ultimately thrown away. This is a complete waste of money. This money could have been used in any other productive way to treat the COVID-19 positive patients and bring them back to normalcy.

    As scientists across the globe try to develop a  vaccine, it is essential to know and address the U.S. healthcare issue that is gradually showing up. It will help to flatten the curve effectively.

     

    SEE COMMENTS

    Leave a Reply